Skip to main
CLSD
CLSD logo

Clearside Biomedical (CLSD) Market Capitalization Overview

Market Cap: $62.17M as of Jun 13, 2025

$62.17M
Past Month-$4.65M (6.95%)
As of Jun 13, 2025, Clearside Biomedical (CLSD) has a market capitalization of $62.17M. Over the past 30 days, its market cap has decreased by -12.65%, while in the last 12 months, it has decreased by -13.72%.

Market capitalization represents the total value of Clearside Biomedical as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Clearside Biomedical (CLSD) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Clearside Biomedical (CLSD) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Clearside Biomedical (CLSD) Market Cap History

DateMarket CapChange
Jun 2, 2025$57.50M-12.65%
May 1, 2025$65.83M-5.98%
Apr 1, 2025$70.02M+16.49%
Mar 3, 2025$60.11M-15.69%
Feb 3, 2025$71.30M-1.57%
Jan 2, 2025$72.44M-12.39%

Clearside Biomedical (CLSD) End of Year Market Cap History

DateMarket CapChange
2025$62.17M-13.72%
2024$72.06M-1.32%
2023$73.02M+8.31%
2022$67.42M-58.91%
2021$164.09M+23.85%
2020$132.49M

FAQs About Clearside Biomedical (CLSD) Market Cap

As of Jun 13, 2025, the market capitalization of Clearside Biomedical (CLSD) is $62.17M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Clearside Biomedical’s market capitalization has decreased by -6.95%, changing from $66.81M to $62.17M as of Jun 13, 2025.

In the last 3 months, Clearside Biomedical’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Clearside Biomedical’s market capitalization decreased from $73.02M in January to $72.06M in December, reflecting a -1.32% change.

In the past five years, Clearside Biomedical (CLSD) has had a compound annual growth rate (CAGR) of -11.47% in market capitalization. This means its market cap has shrunk at an average rate of -11.47% per year.

Clearside Biomedical (CLSD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.